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Abstract
Background: It is not yet clear if blood pressure and renal function changes evolve differently in children with a
congenital or acquired solitary functioning kidney. This study aims to assess if there are any differences between
these two types of solitary kidney patients.
Methods: Current research is a retrospective study assessing the evolution of glomerular filtration rate, proteinuria,
and blood pressure in clinical records of 55 children with a solitary functioning kidney (37 congenital and 18 acquired).
We used the medical records of children who had been assisted, in our unit of pediatric nephrology, for a period of
14 years (168 months), from the time of diagnosis, between January/1997 and December/2015.
Results: During the study period, glomerular filtration rate (T0 128.89 ± 32.24 vs T14 118.51 ± 34.45 ml/min/1.
73 m2, p NS) and proteinuria (T0 85.14 ± 83.13 vs T14 159.03 ± 234.66 mg/m2/die, p NS) demonstrated no significant
change. However, after 14 years of follow-up 76.4% of patients had increased levels of arterial hypertension with values
over the 90th percentile for gender, age, and height. Specifically, children with an acquired solitary functioning kidney
mainly developed hypertension [T0 2/17 (12%) vs T14 9/17 (52.9%) p < 0.025], whereas children with a congenital
solitary functioning kidney mainly developed pre-hypertension [T0 3/38 (7.9%) vs T14 17/38 (44.7%) p < 0.0005].
Conclusions: The renal function of children with solitary functioning kidneys remains stable during a follow-up of
14 years. However, these children should be carefully monitored for their tendency to develop arterial blood pressure
greater than the 90th percentile for gender, age, and height.
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Background
In the 1980s, Brenner et al. [1–3] theorized, based on
observational animals models, that the compensatory
hypertrophy of the solitary functioning kidney (SFK)
would cause hyperfiltration in the residual nephrons;
leading to proteinuria and arterial hypertension and
finally glomerulosclerosis and End Stage Renal Disease
(ESRD) would happen. Human studies in SFK patients
reported conflicting results. Siomou et al. [4] reported
an increase of blood pressure Z-score values; while renal
function and microalbumin urinary excretion were
normal among congenital SFK children compared to
control group. Contradictory, Dursun et al. [5] found a
reduced renal function accompanied with normal blood
pressure. While Shirzai et al. [6] found increased levels
of 24-h urinary microalbumin only in children suffering
from SFK with longer than 5-year duration since onset.
On the other hand, Seeman et al. [7] reported blood
pressure increase and reduced renal function in SFK
children with abnormalities of their residual kidney.
Therefore, Siomou [4] highlighted the importance of
increased serial controls in case of glomerular hyperfiltra-
tion signs; whereas Shirzai [6] supported clinical controls
for the possible onset of microalbuminuria, only for
subjects suffering from SFK for more than 5 years. Finally,* Correspondence: riccardo.lubrano@uniroma1.it1Pediatric Department, Pediatric Nephrology Unit, Sapienza University of
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Seeman [7] recommended strict clinical observation only
for children with SKF and renal scarring.
Present study conducted a retrospective approach in a
population of SFK children, in order to assess changes in
renal function (glomerular filtration rate and proteinuria)
and arterial blood pressure according to the congenital or
acquired nature of the diseases. Patients were followed
over a 168-month observation period.
Methods
Study population
This is a retrospective study based on the clinical
records of pediatric patients with congenital or acquired
SFK, with an observation time of 14 years (168 months).
Current study aimed to assess if the nature of SFK
(congenital vs. acquired) has a different influence on
blood pressure and renal function.
Inclusion and exclusion criteria
We enclosed all children referred to our center with a
diagnosis of SFK that were aged between 3 months and
18 years at diagnosis; and followed them at our day
hospital for 14 years. SFK subjects were divided into two
groups: congenital SFK (cSFK) and acquired SFK (aSFK).
The cSFK group included patients with one kidney
found absent or significantly smaller at ultrasound, with
no detectable renal function or glomerular filtration rate
(GFR) <10 ml/min/1.73 m2 at Tc-99 m DTPA renal
scintigraphy, and no history of surgical nephrectomy.
The aSFK group included SFK patients with complete
absence of one kidney due to previous mono-lateral total
nephrectomy due to trauma.
Exclusion criteria included previous treatment with
drugs potentially affecting renal function, documented
orthostatic proteinuria, congenital anomalies of the
urinary tract and SFK due to previous nephrectomy for
causes other than trauma.
Protocol of the study
For each patient, glomerular filtration rate, proteinuria,
and blood pressure at the time of first admission (T0)
and at 14 years (T14) were extrapolated from the
records stored in our center for pediatric nephrology.
1) For the evaluation of renal function
– We measured proteinuria in 24-h urine collections
as described previously [8]. In case of lack of
voluntary control of micturition, we collected
the urine for 8 h in daytime via urinary collection
bags connected to a binder (U-Bag® Urine Specimen
Collector).
– We used the Tc-99 m DTPA renal scintigraphy
to measure the GFR of the two kidneys separately
[9] and Tc-99 m DMSA renal scintigraphy to
detect the presence of renal scars [10]
– As normal values, we assumed: GFR >90 ml/
min/1.73 m2 [11, 12] and proteinuria <100 mg/
m2/24 h [13].
2) Measurement, evaluation, and classification of blood
pressure:
In children <120 cm in height we only took blood
pressure manually with a mercury
sphygmomanometer (clinical blood pressure). In
children ≥120 cm in height we added a 24-h
ambulatory blood pressure monitoring (ABPM)
applying the technical modalities described
previously [14]. For all blood pressure measures we
used a cuff appropriate to the size of the child’s
upper arm according to the Fourth Report [15]. To
classify the blood pressure status of the children we
used centiles and the classification schemes of the
following guidelines :
– In children between 0 and 18 years:
– Clinical blood pressure classification:
– In children less than 1 year, the tables for
diagnosis of neonatal hypertension were
used [16]
– In children between 1 and 18 years, we
used “the Fourth Report on the Diagnosis,
Evaluation and Treatment of High Blood
Pressure in Children and Adolescents” [15].
as it separates 1) normal blood pressure, 2)
hypertension, and 3) prehypertension.
– ABPM classification:
– The updated recommendations for the
standard assessment of ABPM in children
and adolescent were applied [17] which
combines clinical blood pressure and
ABPM value
– as it separates 1) normal blood pressure, 2)
hypertension, and 3) prehypertension, 4)
masked hypertension, and 5) with white
coat hypertension
– In patients older than 18 years:
– The guidelines set by the European Society of
Cardiology for the assessment of clinical blood
pressure and ABPM were followed [18].
– as it separates adults with In 1) normal blood
pressure, 2) hypertension, and 3)
prehypertension, 4) masked hypertension, and
5) with white coat hypertension
Ethical considerations
The study protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki as revised in 2000
[19] and was approved by the ethic committee of our
institutions.
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Statistical analysis
For statistical evaluation, we used a dedicated software:
JMP (produce of SAS Institute Inc. Cary, NC 27513–2414,
USA) e GraphPad 5.0 (La Jolla, CA, U.S.A.). We expressed
the qualitative variables as percent and the quantitative as
mean ± standard deviation. We analyzed the differences
between the groups using the chi-square (χ2) test for data
expressed as percent. For the data expressed as mean ±
standard deviation we tested the approximation to normal
of the distribution of the population by Kolmogorov-
Smirnov One-Sample Test and statistics for kurtosis and
symmetry. As results were asymmetrically distributed,
non-parametric tests were used (Wilcoxon test).
We considered the differences with p < 0.05 significant.
Results
Characteristics of the study population
We examined the clinical records of 61 patients (44 males
and 17 females) during 14 years after diagnosis at our
center. Among them, 6 patients were excluded. Two of
them had nephrectomy secondary to Wilms tumor, and
four were affected by vesicoureteral reflux. Among
remaining 55 patients (40 males and 15 females), 38
patients had congenital SFK and 17 of them experienced
acquired form.
The mean age at diagnosis was significantly lower
(p < 0.001) in the cSFK group (6.24 ± 3.55 months)
compared to the aSFK group (95.11 ± 33.12 months).
Causes of cSFK included unilateral renal agenesis in
21, congenital aplasia/hypoplasia in 8, and multicystic
kidney disease in 9 children.
Renal function
In Table 1 we report mean values of GFR and proteinuria
in total population, and their mean values in each of the
two subgroups (aSFK and cSFK) at T0 and T14. No
significant differences between these groups were
detected.
The number of subjects with renal scar was similar at
T0 in both groups (cSFK 10/38 vs aSFK 4/17 p NS);
while it was significantly increased at T14 in subjects
with cSFK (T0 10/38 vs T14 24/38 p < 0.003). This value
remained stable in aSFK patients during the course of
follow-up (T0 4/17 vs T14 5/17 p NS).
Hypertension
Table 2 illustrates the partition of SFK patients congenital
and acquired in normotensive, prehypertensive, and
hypertensive at T0 and T14.
At T0, blood pressure was above the 90th centile in 12
children (22%), equally divided between prehypertensive
(11%) and hypertensive (11%). At T14 (end of the study
period) the number of children with blood pressure >90th
centile had increased to 42 (76.4%) (T0 vs T14 p <0.0001);
which 22 (40%) of them were prehypertensive and
20 (36.4%) were hypertensive (Table 2). Particularly,
there was a significant increase of prehypertension
(PreHyp) in the cSFK group (T0 3/38 vs T14 17/38
p <0.0005), as well as a significant increase of
hypertension (Hyp) in the aSFK group (T0 2/17 vs
T14 9/17 p <0.025) (Table 2).
In particular, subjects with renal scars and hypertension
where distributed as follows:
– Acquired solitary functioning kidney, 1/17 at T0 and 2/
17 at T14 (i.e., 1/2 hypertensive at T0 and 2/9 at T14)
– Congenital solitary functioning kidney, 2/38 at T0
and 9/38 at T14 p < 0.047 (i.e., 2/4 hypertensive at
T0 and 9/11 at T14)
In our study we did not detect any subjects with
masked hypertension or white coat hypertension.
Discussion
Current study showed that during a 168-month follow up
of children with congenital or acquired solitary
functioning kidney, renal functions did not change
significantly and blood pressure increased up to over the
90th centile in 76.4% of the studied population. These
findings are in agreement with the results of Siomou et al.
[4], but in contrast with other reports [5, 6] outlining an
alteration of the renal function and/or normal blood
pressure values. In our study, children with high blood
pressure have apparently normal renal function. What we
found, may also be due to the fact that, as described in the
literature, nearly 50% of SFK patients have a reduced renal
functional reserve [20]: this might help to explain why it is
possible to observe the development of high blood pressure
Table 1 GFR and proteinuria at time of diagnosis (T0) and after 14 years follow-up (T14)
GFR
ml/min/1.73 m^2
Proteinuria
mg/m^2/die
T0 T14 p< T0 T14 p<
SFK 128.89 ± 32.24 118.51 ± 34.45 NS 85.14 ± 83.13 159.03 ± 234.66 NS
aSFK 109.41 ± 33.71 100.72 ± 33.49 NS 61.35 ± 17.15 140.52 ± 122.26 NS
cSFK 126.60 ± 34.98 103.76 ± 46.49 NS 106.30 ± 111.78 147.15 ± 247.46 NS
SFK all solitary functioning kidney patients; aSFK acquired type; cSFK: congenital type
GFR and Proteinuria at T0 and T14: aSFK vs cSFK, SFK vs aSFK, SFK vs cSFK: p NS
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without reduction in glomerular filtration rate or increase
of serum creatinine levels.
However the higher incidence of subjects with hyper-
tension as shown in our study, albeit higher, is in
agreement with those of the KIMONO study (21%) [21,
22]. We believe that the higher hypertension percentage
we found, in our study, could be due to the use of
ABPM method of measurement, actually representing
the most reliable technic of measurement of blood
pressure in children [5, 14]. In our study, contrary to
other authors [23], we did not detect any cases of
masked hypertension. However, we detected a higher
number of hypertensive subjects, possibly because of the
longer period of follow-up. We suspect that a number of
children developed masked hypertension first and by the
time they reached the age when we could use ABPM
they had progressed to hypertension.
We measured the blood pressure with ABPM at T0
and T14 whenever feasible, i.e., when the child height is
≥120 cm. This was always the case with SFK patients
acquired type, but SFK patients congenital type where
first observed at a very young age, and ABPM could not
be used at T0. It was therefore necessary to compare the
IV Report classification [15] with the updated recommen-
dations for the standard assessment of ABPM in children
and adolescents [17].). We should observe that data offered
by office blood pressure alone do not diverge from the
integration of office blood pressure and ABPM. We still
support the use of ABPM as it detects white coat hyperten-
sion and masked hypertension, and it is the best available
tool to assess the effects of antihypertension therapy in the
24 h time span. Nevertheless, the peculiarity of our results
is in the classification of the blood pressure status of the
subjects who develop values higher than the 90th centile.
Up to 36.40% of patients developed hypertension and up to
40% prehypertension; while the former was mostly
observed in the acquired SFK group and the latter in the
congenital SFK.
Our data differs from a later report by Westland et
al. [23] showing a 26% incidence of hypertension and
11% pre-hypertension in children with SFK with a
non-statistical significant different distribution between
acquired and congenital types of SFK.
Furthermore, our findings have distinct characteristics
compared to the reports by Seeman et al. [7]. This study
reported hypertension only in cSFK that developed renal
scars. On the contrary our finding support hypertension
to be more frequently found in association with aSFK; a
group of patients who developed a lesser number of
renal scars. This observation seems in accordance with a
report by Jaoudé et al. suggesting that compensation of
renal metabolism by the residual kidney may be more
difficult in cases of nephrectomy following trauma [24]
and this could account for the higher development of
hypertension. We should not underestimate the influence
of renal scars on the onset of hypertension. In fact,
contrary to acquired solitary functioning kidneys, in the
congenital group the number of hypertensive subjects
with renal scars increases significantly from T0 to T14. It
is worth noting that children with vesicoureteral reflux
were excluded from this study. Also of interest, Maheen et
al. [25] observed that 21% of otherwise healthy children
with newly diagnosed hypertension had renal scars.
Seeman et al. [7] recommend a close follow-up for hyper-
tension for all children with renal scars in SFK.
Current study also highlights the presence of prehy-
pertension in 40% of the cases; a condition that we
believe requires a close observation. Since prehypertension
state is prone to develop into hypertension [26, 27], its early
detection in SFK children should be taken into con-
sideration. Therefore adequate renal protective treat-
ment and blood pressure control in these patients
should be promptly instituted [28]. Moreover, the
increase in blood pressure should be also treated with
an increase of sport activity; since it tends to improve
the cardiorespiratory fitness in children with SFK [29]
and kidney transplantation [30].
Conclusions
In view of the significant increase in blood pressure
over a 14 year follow-up, we suggest prolonged
mandatory follow-up of blood pressure every 6 months
in children with both acquired and congenital SFK; in
view of the higher incidence of prehypertension and
hypertension that we found in this population, we
consider it more appropriate than the yearly control
suggested by Westland et al. [23]. The screening for
Table 2 Blood pressure at time of diagnosis (T0) and after
14 years follow-up (T14)
T0 T14 T0 vs T14 p<
SFK with BP > 90%thile 12/55 (22%) 42/55 (76.4%) 0.0001
aSFK 5/17 (29%) 14/17 (82.4%) 0.005
cSFK 7/38 (18%) 28/38 (73.7%) 0.0001
PreHyp-SFK 6/55 (10.9%) 22/55 (40%) 0.0008
PreHyp-aSFK 3/17 (17.6%) 5/17 (29.4%) NS
PreHyp-cSFK 3/38 (7.9%) 17/38 (44.7%) 0.0005
Hyp-SFK 6/55 (11%) 20/55 (36.4%) 0.003
Hyp-aSFK 2/17 (12%) 9/17 (52.9%) 0.025
Hyp-cSFK 4/38 (10%) 11/38 (29%) NS
SFK all solitary functioning kidney patients; aSFK acquired type; cSFK
congenital type
PreHyp-aSFK: acquired solitary functioning kidney patients
with prehypertension
PreHyp-cSFK: congenital solitary functioning kidney patients
with prehypertension
Hyp-aSFK: acquired solitary functioning kidney patients with hypertension
Hyp-cSFK: congenital solitary functioning kidney patients with hypertension
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hypertension should be conducted by clinic blood
pressure as well as by ABPM.
Specific attention should be given to the screening of
patients for suspect prehypertension; as these children
could definitely benefit from simple changes in life style
and the early institution of an adequate medical therapy,
that effectively prevent the clinical consequences and
contrast the progression to hypertension [8].
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